These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8396634)

  • 21. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
    Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary-adrenocortical response to acute and chronic administration of U-50,488H in the rat.
    Milanés MV; Gonzalvez ML; Fuente T; Vargas ML
    Neuropeptides; 1991 Oct; 20(2):95-102. PubMed ID: 1665898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I; Spetea M
    Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor.
    Eisenberg RM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):985-91. PubMed ID: 8394926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna ; Reddy PL; Bhargava HN
    Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
    Xia Q; Sheng JZ; Tai KK; Wong TM
    J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
    Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat.
    Friese N; Diop L; Lambert C; Rivière PJ; Dahl SG
    Life Sci; 1997; 61(16):1559-70. PubMed ID: 9353165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.